Results 11 to 20 of about 288,723 (312)
Immunotherapy for advanced gastric cancer
World Journal of Methodology, 2023 Gastric cancer (GC) is believed to be the fifth most common cancer and the third most common cause of death worldwide. Treatment techniques include radiation, chemotherapy, gastrectomy, and targeted treatments are often employed. Some hopeful results from the development of GC immunotherapy have already changed treatment approaches. Along with previous
Leowattana, Wattana +2 more
openaire +2 more sources
Research Status and Progress on Treatment of Advanced Gastric Cancer
Zhongliu Fangzhi Yanjiu, 2022 Gastric cancer is one of the most common malignant tumors worldwide. The number of gastric cancer cases and related deaths in China accounts for almost half of the global data. The survival prognosis of advanced gastric cancer is poor.
DONG Caixia, YUAN Ying
doaj +1 more source
Minimally invasive surgery in advanced gastric cancer
Annals of Gastroenterological Surgery, 2022 Since Dr. Kitano introduced laparoscopic distal gastrectomy for early gastric cancer in 1994, there have been remarkable advances in minimally invasive surgery (MIS) for gastric cancer, including robotic surgery.
Sangjun Lee, Hyung‐Ho Kim
doaj +1 more source
Advancing early gastric cancer detection [PDF]
FEBS Open Bio, 2021 Important factors in combating cancer are early detection and accurate assessment of the best course of treatment. In a study published in this issue, Wang et al. identify possible miRNA biomarkers for improved determination of gastric cancer stage and prognosis.
openaire +4 more sources
Gastric Cancer at a University Teaching Hospital in Northwestern Tanzania: A Retrospective Review of 232 Cases. [PDF]
, 2012 Despite marked decreases in its incidence, particularly in developed countries, gastric cancer is still the second most common tumor worldwide. There is a paucity of information regarding gastric cancer in northwestern Tanzania. This study was undertaken
Chalya, Phillipo L +7 more
core +3 more sources
Clinical Endoscopy, 2013 Improvements in the endoscopic evaluation and management of gastric cancer have made it possible to determine the depth of invasion during endoscopic examination. The aim of this study was to elucidate the differences between early gastric cancer (EGC) that resembles advanced gastric cancer (AGC) and AGC that resembles EGC.We retrieved cases of EGC ...
Park, Hyun Sik +7 more
openaire +2 more sources
Claudin18.2 in Advanced Gastric Cancer
Cancers, 2023 Globally, the fifth most common cancer and the fourth leading cause of cancer-related mortality is gastric cancer (GC). Recent clinical trials on solid tumors enrolled patients who possess druggable genetic alterations, protein expression, and immune characteristics. In gastric or gastroesophageal junction (GEJ) cancers, trastuzumab combined with first-
Inamoto, Rin +2 more
openaire +2 more sources
Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency [PDF]
, 2018 An increased prevalence of malignant lymphoma and of gastric cancer has been observed in large cohorts of patients with common variable immunodeficiency (CVID), the most frequently symptomatic primary immunodeficiency. Surveillance strategies for cancers
Agostini, Carlo +11 more
core +3 more sources
A phase II multicentre, open-label, proof-of-concept study of tasquinimod in hepatocellular, ovarian, renal cell, and gastric cancers [PDF]
, 2017 Background: Tasquinimod is a small molecule with immunomodulatory, anti-angiogenic, and anti-metastatic properties that targets the tumor microenvironment.
Bjarnason, Georg A +14 more
core +1 more source
Frontiers in Surgery, 2021 Background: Advanced gastric cancer is the fifth leading cause of cancer-related deaths. Patients with metastatic advanced gastric cancer commonly develop a gastric outlet obstruction that considerably worsens their quality of life.
Chunfang Lin +3 more
doaj +1 more source